Arsela Prelaj

ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Venues

Current oncology (Toronto, Ont.)

Healthcare (Basel, Switzerland)

Journal of personalized medicine

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Denis Horgan, Marc Van den Bulcke, Umberto Malapelle, Nicola Normanno, Ettore D Capoluongo, Arsela Prelaj, Carmelo Rizzari, Aliki Stathopoulou, Jaya Singh, Marta Kozaric, France Dube, Manuel Ottaviano, Stefania Boccia, Gabriella Pravettoni, Ivana Cattaneo, Núria Malats, Reinhard Buttner, Karim Lekadir, Francesco de Lorenzo, Patricia Blanc, Catherine Alix-Panabières, Sara Badreh, Paul Hofman, Eric Solary, Ruggero De Maria
Aligning Cancer Research Priorities in Europe with Recommendations for Conquering Cancer: A Comprehensive Analysis. Healthcare (Basel, Switzerland) 12 (2) (2024)
Denis Horgan, Marc Van den Bulcke, Umberto Malapelle, Nicola Normanno, Ettore D Capoluongo, Arsela Prelaj, Carmelo Rizzari, Aliki Stathopoulou, Jaya Singh, Marta Kozaric, France Dube, Manuel Ottaviano, Stefania Boccia, Gabriella Pravettoni, Ivana Cattaneo, Núria Malats, Reinhard Buttner, Karim Lekadir, Francesco de Lorenzo, Catherine Alix-Panabières, Sara Badreh, Eric Solary, Ruggero De Maria, Paul Hofman
Demographic Analysis of Cancer Research Priorities and Treatment Correlations. Current oncology (Toronto, Ont.) 31 (4) (2024)
Denis Horgan, Marc Van den Bulcke, Umberto Malapelle, Nicola Normanno, Ettore D Capoluongo, Arsela Prelaj, Carmelo Rizzari, Aliki Stathopoulou, Jaya Singh, Marta Kozaric, France Dube, Manuel Ottaviano, Stefania Boccia, Gabriella Pravettoni, Ivana Cattaneo, Núria Malats, Reinhard Buttner, Karim Lekadir, Francesco de Lorenzo, Catherine Alix-Panabières, Sara Badreh, Eric Solary, Ruggero De Maria, Paul Hofman
Demographic Analysis of Cancer Research Priorities and Treatment Correlations. Current oncology (Toronto, Ont.) 31 (4) (2024)
Denis Horgan, Marc Van den Bulcke, Umberto Malapelle, Nicola Normanno, Ettore D Capoluongo, Arsela Prelaj, Carmelo Rizzari, Aliki Stathopoulou, Jaya Singh, Marta Kozaric, France Dube, Manuel Ottaviano, Stefania Boccia, Gabriella Pravettoni, Ivana Cattaneo, Núria Malats, Reinhard Buttner, Karim Lekadir, Francesco de Lorenzo, Patricia Blanc, Catherine Alix-Panabières, Sara Badreh, Paul Hofman, Eric Solary, Ruggero De Maria
Aligning Cancer Research Priorities in Europe with Recommendations for Conquering Cancer: A Comprehensive Analysis. Healthcare (Basel, Switzerland) 12 (2) (2024)
Denis Horgan, Marc Van den Bulcke, Umberto Malapelle, Nicola Normanno, Ettore D Capoluongo, Arsela Prelaj, Carmelo Rizzari, Aliki Stathopoulou, Jaya Singh, Marta Kozaric, France Dube, Manuel Ottaviano, Stefania Boccia, Gabriella Pravettoni, Ivana Cattaneo, Núria Malats, Reinhard Buttner, Karim Lekadir, Francesco de Lorenzo, Catherine Alix-Panabières, Sara Badreh, Eric Solary, Ruggero De Maria, Paul Hofman
Demographic Analysis of Cancer Research Priorities and Treatment Correlations. Current oncology (Toronto, Ont.) 31 (4) (2024)
Denis Horgan, Marc Van den Bulcke, Umberto Malapelle, Nicola Normanno, Ettore D Capoluongo, Arsela Prelaj, Carmelo Rizzari, Aliki Stathopoulou, Jaya Singh, Marta Kozaric, France Dube, Manuel Ottaviano, Stefania Boccia, Gabriella Pravettoni, Ivana Cattaneo, Núria Malats, Reinhard Buttner, Karim Lekadir, Francesco de Lorenzo, Catherine Alix-Panabières, Sara Badreh, Eric Solary, Ruggero De Maria, Paul Hofman
Demographic Analysis of Cancer Research Priorities and Treatment Correlations. Current oncology (Toronto, Ont.) 31 (4) (2024)
Giuseppe Lo Russo, Arsela Prelaj, James Dolezal, Teresa Beninato, Luca Agnelli, Tiziana Triulzi, Alessandra Fabbri, Daniele Lorenzini, Roberto Ferrara, Marta Brambilla, Mario Occhipinti, Laura Mazzeo, Leonardo Provenzano, Andrea Spagnoletti, Giuseppe Viscardi, Francesco Sgambelluri, Silvia Brich, Vanja Miskovic, Alessandra Laura Giulia Pedrocchi, Francesco Trovo', Sara Manglaviti, Claudia Giani, Paolo Ambrosini, Rita Leporati, Andrea Franza, John McCulloch, Tommaso Torelli, Andrea Anichini, Roberta Mortarini, Giorgio Trinchieri, Giancarlo Pruneri, Valter Torri, Filippo De Braud, Claudia Proto, Monica Ganzinelli, Marina Chiara Garassino
PEOPLE (NTC03447678), a phase II trial to test pembrolizumab as first-line treatment in patients with advanced NSCLC with PD-L1 <50%: a multiomics analysis. Journal for immunotherapy of cancer 11 (6) (2023)
Emma Zattarin, Sara Manglaviti, Giulia Apollonio, Teresa Beninato, Laura Mazzeo, Giacomo Massa, Achille Bottiglieri, Edoardogregorio Galli, Alessandro De Toma, Mario Occhipinti, Marta Brambilla, Roberto Ferrara, Monica Ganzinelli, Claudia Proto, Marina Chiara Garassino, Filippo de Braud, Giuseppe Lo Russo, Arsela Prelaj
Prognostic role of neutrophil-to-lymphocyte ratio and EPSILoN score in advanced non-small-cell lung cancer patients treated with first-line chemo-immunotherapy. Future oncology (London, England) 18 (23) (2022)
Arsela Prelaj, Mattia Boeri, Alessandro Robuschi, Roberto Ferrara, Claudia Proto, Giuseppe Lo Russo, Giulia Galli, Alessandro De Toma, Marta Brambilla, Mario Occhipinti, Sara Manglaviti, Teresa Beninato, Achille Bottiglieri, Giacomo Massa, Emma Zattarin, Rosaria Gallucci, Edoardo Gregorio Galli, Monica Ganzinelli, Gabriella Sozzi, Filippo G M de Braud, Marina Chiara Garassino, Marcello Restelli, Alessandra Laura Giulia Pedrocchi, Francesco Trovo'
Machine Learning Using Real-World and Translational Data to Improve Treatment Selection for NSCLC Patients Treated with Immunotherapy. Cancers 14 (2) (2022)
Mario Alberto Occhipinti, Marta Brambilla, Giulia Galli, Sara Manglaviti, Maristella Giammaruco, Arsela Prelaj, Roberto Ferrara, Alessandro De Toma, Claudia Proto, Teresa Beninato, Emma Zattarin, Giuseppe Lo Russo, Alain Jonathan Gelibter, Maurizio Simmaco, Robert Preissner, Marina Chiara Garassino, Filippo De Braud, Paolo Marchetti
Evaluation of Drug-Drug Interactions in EGFR-Mutated Non-Small-Cell Lung Cancer Patients during Treatment with Tyrosine-Kinase Inhibitors. Journal of personalized medicine 11 (5) (2021)
Leonardo Provenzano, Valeria Cuccarini, Marco Platania, Luca Canziani, Andrea Spagnoletti, Fabio M Doniselli, Marica Eoli, Arsela Prelaj, Elena Anghileri
Carcinomatosis under control by osimertinib in EGFR and TP53 mutated lung adenocarcinoma. Tumori 107 (6) (2021)

Arsela Prelaj.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Arsela Prelaj